secwatch.observer — SEC 8-K summary
======================================

Issuer:     COOPER COMPANIES, INC. (COO)
CIK:        0000711404
Form:       8-K
Filed at:   2021-12-17T23:59:59+00:00
Accession:  0001193125-21-361145
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.85
Item codes: 1.01, 2.01, 2.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CooperCompanies completes $1.6B acquisition of Generate Life Sciences, funded by $1.5B term loan
--------------------------------------------------------------------------------

- Cooper completed acquisition of Generate Life Sciences for ~$1.605B in cash.
- Generate provides donor egg/sperm, fertility cryopreservation, and newborn stem cell storage.
- Acquisition funded by a $1.5B non-amortizing 5-year senior unsecured term loan.
- Term loan matures Dec 17, 2026; bears interest at LIBOR + 75bps or base rate.
- CooperSurgical adds Generate to strengthen fertility clinic and Ob/Gyn offerings.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/711404/000119312521361145/0001193125-21-361145-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/711404/000119312521361145/d272863d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-361145

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer